3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Advanced Solid Tumor
6
Carcinoma, Hepatocellular
4
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Advanced Solid Tumors
2
Advanced Lung Cancer
2
Urinary Bladder Neoplasms
1
Treatment-naive Advanced Non-small Cell Lung Cancer
1
Sarcoma
1
Recurrence
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma
1
Locally Advanced or Metastatic Solid Tumors
1
Locally Advanced Rectal Cancer
1
Liver Neoplasms
1
Liver Diseases
1
Kidney Neoplasms
1
High-Risk Resectable NSCLC
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Chondrosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy
1
Interventions
toripalimab
1
Vinorelbine
1
Platinum Compounds
1
Nivolumab
1
Ipilimumab
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Non Small Cell Lung Cancer
×
toripalimab
×
Clear all
NCT04144608
2024-08-09
TOGATHER
Hunan Province Tumor Hospital
Phase 2
Completed
40 enrolled